User profiles for David Brown

David R. Brown

- Verified email at nsf.gov - Cited by 121409

David M Brown MD FACS

- Verified email at houstonretina.com - Cited by 74090

David W Brown

- Verified email at pivot235.org - Cited by 17816

Theory and applications of robust optimization

D Bertsimas, DB Brown, C Caramanis - SIAM review, 2011 - SIAM
In this paper we survey the primary research, both theoretical and applied, in the area of robust
optimization (RO). Our focus is on the computational attractiveness of RO approaches, as …

[HTML][HTML] RAS is regulated by the let-7 microRNA family

…, R Jarvis, A Cheng, E Labourier, KL Reinert, D Brown… - Cell, 2005 - cell.com
MicroRNAs (miRNAs) are regulatory RNAs found in multicellular eukaryotes, including
humans, where they are implicated in cancer. The let-7 miRNA times seam cell terminal …

Management control systems as a package—Opportunities, challenges and research directions

T Malmi, DA Brown - Management accounting research, 2008 - Elsevier
There has been very little explicit theoretical and empirical research on the concept of
management control systems (MCS) as a package despite the existence of the idea in …

[PDF][PDF] Associations between physical activity dose and health-related quality of life

DW Brown, DR Brown, GW Heath, L Balluz… - Medicine & Science in …, 2004 - academia.edu
BROWN, DW, DR BROWN, GW HEATH, L. BALLUZ, WH GILES, ES FORD, and AH MOKDAD.
Associations between Physical Activity Dose and Health-Related Quality of Life. Med. Sci. …

[HTML][HTML] Transcatheter or surgical aortic-valve replacement in intermediate-risk patients

…, JW Moses, A Trento, DL Brown… - … England Journal of …, 2016 - Mass Medical Soc
Background Previous trials have shown that among high-risk patients with aortic stenosis,
survival rates are similar with transcatheter aortic-valve replacement (TAVR) and surgical …

[HTML][HTML] Ranibizumab for neovascular age-related macular degeneration

PJ Rosenfeld, DM Brown, JS Heier… - … England Journal of …, 2006 - Mass Medical Soc
Background Ranibizumab — a recombinant, humanized, monoclonal antibody Fab that
neutralizes all active forms of vascular endothelial growth factor A — has been evaluated for the …

[HTML][HTML] Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients

…, MR Williams, JM McCabe, DL Brown… - … England Journal of …, 2019 - Mass Medical Soc
Background Among patients with aortic stenosis who are at intermediate or high risk for
death with surgery, major outcomes are similar with transcatheter aortic-valve replacement (…

[HTML][HTML] Ranibizumab versus verteporfin for neovascular age-related macular degeneration

DM Brown, PK Kaiser, M Michels… - … England Journal of …, 2006 - Mass Medical Soc
Background We compared ranibizumab — a recombinant, humanized, monoclonal
antibody Fab that neutralizes all active forms of vascular endothelial growth factor A — with …

Sorption of hydrophobic pollutants on natural sediments

SW Karickhoff, DS Brown, TA Scott - Water research, 1979 - Elsevier
The sorption of hydrophobic compounds (aromatic hydrocarbons and chlorinated hydrocarbons)
spanning a concentration range in water solubility from 500 parts per trillion (ppt) to …

Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration

JS Heier, DM Brown, V Chong, JF Korobelnik… - Ophthalmology, 2012 - Elsevier
OBJECTIVE: Two similarly designed, phase-3 studies (VEGF Trap-Eye: Investigation of
Efficacy and Safety in Wet AMD [VIEW 1, VIEW 2]) of neovascular age-related macular …